Bingham Gwendolyn M 4
Research Summary
AI-generated summary
ACCENDRA HEALTH (ACH) Director Gwendolyn Bingham Receives Award
What Happened
Gwendolyn M. Bingham, a director of ACCENDRA HEALTH INC/VA (ACH), was granted 31,191 phantom stock units on 2026-05-14. The Form 4 reports the grant as a derivative award (transaction code A) at an acquisition price of $0.00. Because this is an award of phantom units (not an open-market purchase or sale), there was no cash exchanged at the time of grant.
Key Details
- Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed within the standard 2-business-day reporting window).
- Instrument: 31,191 phantom stock units (derivative award) at $0.00 per unit.
- Transaction code: A (Grant/Award).
- Shares owned after transaction: Not specified in the filing.
- Footnote: The phantom units convert on a 1-for-1 basis and become payable, at the reporting person’s election, in cash or common stock upon one of the following events: (a) death, (b) disability, (c) termination of service as director, (d) a specified future delivery date, or (e) the earliest to occur of (a)–(d).
Context
This was an equity-linked award (phantom stock units) rather than an open-market buy or sale; such awards create a contingent right to receive cash or shares in the future and do not represent immediate common-share ownership or sale. Because no cash was paid and no shares were immediately issued, the grant should be viewed as a compensation event rather than a direct market bet by the insider.